Skip to content

Construction of a prevention plan for lower limb lymphedema in patients with gynecological malignant tumors after surgery and a multicenter clinical application study

Construction of a prevention plan for lower limb lymphedema in patients with gynecological malignant tumors after surgery and a multicenter clinical application study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070018
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecology malignant tumor

Interventions

experimental group:To implement the established prevention program of lower limb lymphedema for gynecological malignant tumor patients after operation
Control group:Routine postoperative care and treatment

Sponsors

Hainan Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Histopathological diagnosis of cervical cancer, endometrial cancer, vulvar cancer, ovarian cancer; Surgical treatment with pelvic or inguinal or aortic lymphadenectomy; =18 years of age; Volunteer.

Exclusion criteria

Exclusion criteria: Lower limb venous thrombosis, chronic venous insufficiency, heart, liver, kidney and other important organ failure, hypoproteinemia; Patients with other cancers or cancer recurrence or metastasis during the study period; Mentally unable to complete rehabilitation training; Patients who required a change in treatment strategy due to other postoperative complications during the study period.

Design outcomes

Primary

MeasureTime frame
Incidence of lower limb lymphedema;Stage of lower limb lymphedema;

Secondary

MeasureTime frame
Self-reported symptoms;Life quality;Brief fatigue scale score;

Countries

China

Contacts

Public ContactHuanying Yi

Hainan Medical University

m15248936373@163.com15248936373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026